Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/169208
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | MT1-MMP as a PET imaging biomarker for pancreas cancer management |
Autor: | Morcillo, Miguel Ángel; García de Lucas, Ángel; Oteo, Marta; Romero, Eduardo; Magro, Natalia; Ibáñez, Marta; Martínez, Alfonso; Garaulet, Guillermo; Arroyo, Alicia G. CSIC ORCID ; López-Casas, Pedro P. CSIC ORCID; Hidalgo, Manuel CSIC ORCID; Mulero, Francisca; Martínez-Torrecuadrada, Jorge Luis | Fecha de publicación: | 26-ago-2018 | Editor: | Hindawi Publishing Corporation | Citación: | Contrast Media & Molecular Imaging 8382148 (2018) | Resumen: | Pancreatic ductal adenocarcinoma (PDAC) continues to be one of the deadliest cancers for which optimal diagnostic tools are still greatly needed. Identification of PDAC-specific molecular markers would be extremely useful to improve disease diagnosis and follow-up. MT1-MMP has long been involved in pancreatic cancer, especially in tumour invasion and metastasis. In this study, we aim to ascertain the suitability of MT1-MMP as a biomarker for positron emission tomography (PET) imaging. Two probes were assessed and compared for this purpose, a MT1-MMP-specific binding peptide, MT1-AF7p, and a specific antibody, LEM2/15, labelled respectively with 68Ga with 89Zr. PET imaging with both probes was conducted in patient-derived xenograft (PDX), subcutaneous and orthotopic, PDAC mouse models and in a cancer cell line (CAPAN-2)-derived xenograft (CDX) model. Both radiolabelled tracers were successful in identifying, by means of PET imaging techniques, tumour tissues expressing MT1-MMP although they did so at different uptake levels. The 89Zr-DFOLEM2/ 15 probe showed greater specific activity compared to the 68Ga-labelled peptide. The mean value of tumour uptake for the 89Zr-DFO-LEM 2/15 probe (5.67±1.11 %ID/g, n=28) was 25-30 times higher than that of the 68Ga-DOTA-AF7p ones. Tumour/blood ratios (1.13±0.51 and 1.44±0.43 at 5 and 7 days of 89Zr-DFO-LEM 2/15 post-injection were higher than those estimated for 68Ga-DOTAAF7p probes (of approximately tumour/blood ratio=0.5 at 90 min post-injection). Our findings strongly point out that i) the in vivo detection of MT1-MMP by PET imaging is a promising strategy for PDAC diagnosis and ii) labelled LEM2/15 antibody is a better candidate than MT1-AF7p for PDAC detection. | Descripción: | 13 p.-5 fig. | Versión del editor: | https://doi.org/10.1155/2018/8382148 | URI: | http://hdl.handle.net/10261/169208 | DOI: | 10.1155/2018/8382148 | ISSN: | 1555-4309 | E-ISSN: | 1555-4317 |
Aparece en las colecciones: | (CIB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Contrast Media & Mol. Imag._Morcillo_2018.pdf | Artículo principal | 3,79 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
9
checked on 23-abr-2024
SCOPUSTM
Citations
12
checked on 23-abr-2024
WEB OF SCIENCETM
Citations
10
checked on 25-feb-2024
Page view(s)
362
checked on 24-abr-2024
Download(s)
435
checked on 24-abr-2024